Kangmei Pharma | 600518 - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.38M 172K 2026-03
Cspc Pharmaceutical CNY 11.52B 3.7M 2025-12
Dianthus Therapeutics USD 54.58M 11.36M 2026-03
Genomma Lab Internacional MXN 975.03M 220K 2026-06
Hypermarcas BRL 703.5M 64.04M 2026-03
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
IQVIA Holdings USD 164.6M 2.3M 2026-06
Jiangsu Hengrui CNY 6.64B 0 2026-06
Kangmei Pharma CNY 13.83B 0 2026-03
Moderna USD 391M 2M 2025-09
Organon & Co USD 262.61M 40K 2026-06
Revvity USD 111.63M 174K 2026-06
Sh Fosun Pharma CNY 2.67B 0 2026-06
Tectonic Therapeutic USD 18.83M 92.19K 2026-03
Viatris USD 1.16B 9.19M 2026-06
Wuxi Apptec CNY 2.98B 0 2026-06
Xeris Pharmaceuticals USD 172.56M 6.34M 2026-03
Zz Pientze Pharmaceu CNY 603.32M 0 2026-06